AbCellera Biologics Inc vs Duke Energy Corp — how do they compare? AbCellera Biologics Inc trades at $8.92 (market cap $2.85B), while Duke Energy Corp trades at $122.8 (market cap $94.49B). The key difference: Duke Energy Corp is far larger — about 33.2× AbCellera Biologics Inc's market cap, and Duke Energy Corp pays a 3.58% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | DUK | |
|---|---|---|
Market Cap | $2.85B | $94.49B |
Sector | Health | Utilities |
52-Week High | $9.76 | $133.46 |
52-Week Low | $2.78 | $113.99 |
Enterprise Value | $2.45B | $187.00B |
Dividend Yield | — | 3.58% |
Trailing returns across standard periods
Latest headlines on both assets
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →